Skip to main content

Table 4 Risk of bias assessments for trials included for KQ1a on the benefits and harms of screening vs. no screening, and KQ1b on the comparative benefits and harms of different screening approaches

From: Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools

  1. CCT Clinical controlled trial, PP Per protocol
Back to article page

Systematic Reviews

ISSN: 2046-4053